Pfizer’s first ad campaign for over-the-counter Viagra in the U.K. uses comparisons to illustrate the relative commonplace incidence of erectile dysfunction. Print and out-of-home ads begin with the fact that “4.3 million men in the U.K. experience erectile problems.” The
read moreMinisters from the Department of Health have written a letter asking that Vertex bring negotiations with NHS England over access to cystic fibrosis drug Orkambi “to an urgent resolution”. More: Ministers write letter to Vertex over Orkambi debate Source: News
read moreGerman healthcare firm Fresenius Kabi is walking away from a $4.3-billion merger with US generics group Akorn, claiming that the latter has failed to fulfill several closing conditions. More: Fresenius pulls out of .3bn Akorn merger Source: News
read moreTakeda has put forward a new proposed bid for Shire, increasing the cash portion of the deal. More: Takeda ups its offer for Shire Source: News
read moreAB Science’s share price has taken a hit after European Medicine Agency’s advisors rejected approval of masitinib for amyotrophic lateral sclerosis. More: CHMP rejects AB Science’s ALS drug Source: News
read moreNovartis is hoping its multiple sclerosis candidate siponimod’s performance in secondary progressive patients can help secure it a blockbuster approval. And now it has more data to put toward that case. More: Novartis pads case for new MS blockbuster with
read more© 1994 - 2026 B.M. Pharmaceuticals